Related Experiment Video
Updated: Apr 17, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Headache in a case of tuberculosis: think beyond meningitis-a case report
Sanchit Shailendra Chouksey1, Anand Vardhan Sharma2, Ekagrata Shukla3
1Department of Neurology, Datta Meghe Medical College, DMIHER, Nagpur, Maharashtra, India.
Background:
Intracranial hypertension may be idiopathic (IIH) or due to some underlying causes, such as an intracranial space-occupying lesion or drug induced.
Case Presentation:
A 14-year-old South Asian male was being treated for MDR-TB with anti-tubercular therapy (including levofloxacin) when he developed a headache lasting 8 days. Examination revealed bilateral papilledema. The CSF study was unremarkable. MRI revealed left transverse and sigmoid sinus stenosis. A probable diagnosis of levofloxacin-induced intracranial hypertension was made, and the drug was stopped. The symptoms resolved within 1 week of drug cessation, and the papilledema resolved within 2 weeks.
Conclusions:
Although rare, clinicians must be aware of this side effect of levofloxacin while evaluating a case with recent onset of features of raised ICP and taking this drug as part of some therapy.
Insights
Levofloxacin, an antibiotic for multidrug-resistant tuberculosis, can rarely cause intracranial hypertension. Stopping the drug led to symptom resolution in a teenage patient.
Area of Science:
- Neurology
- Pharmacology
- Infectious Diseases
Background:
- Intracranial hypertension (IIH) can be idiopathic or secondary to causes like tumors or medications.
- Drug-induced intracranial hypertension is a recognized but less common etiology.
Purpose of the Study:
- To report a rare case of levofloxacin-induced intracranial hypertension.
- To highlight the importance of considering medication side effects in patients presenting with symptoms of raised intracranial pressure.
Main Methods:
- A case presentation of a 14-year-old male treated for multidrug-resistant tuberculosis (MDR-TB).
- The patient developed symptoms of increased intracranial pressure during levofloxacin therapy.
- Diagnostic workup included fundoscopy, cerebrospinal fluid analysis, and magnetic resonance imaging (MRI).
Main Results:
- The patient presented with headache and bilateral papilledema.
- MRI revealed left transverse and sigmoid sinus stenosis.
- Discontinuation of levofloxacin resulted in rapid symptom and sign resolution.
Conclusions:
- Levofloxacin can be a potential cause of drug-induced intracranial hypertension.
- Clinicians should maintain a high index of suspicion for this adverse effect in patients on levofloxacin therapy presenting with signs of raised intracranial pressure.
- Prompt recognition and drug cessation are crucial for favorable outcomes.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Viral Meningitis
